Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
The Long Run with Luke Timmerman
Enhancing Clinical Trials and Understanding Immune Interactions
This chapter explores the obstacles in patient enrollment for clinical trials and presents innovative solutions leveraging AI and remote support. It also emphasizes the importance of T-cell receptor interactions with peptide-MHC complexes in advancing cancer immunotherapy.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
